NCT00619112View on ClinicalTrials.gov

Temozolomide in Treating Patients With Recurrent High-Grade Glioma

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2011

Study Completion Date

September 30, 2012

Conditions
Recurrent Central Nervous System Neoplasm
Interventions
DRUG

temozolomide

single arm study

Trial Locations (1)

94115

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, San Francisco

OTHER

NCT00619112 - Temozolomide in Treating Patients With Recurrent High-Grade Glioma | Biotech Hunter | Biotech Hunter